Aigen Investment Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,527	Closed	-$208K	–	1033
2023 Q2	$208K	Buy	+7,527	New	+$208K	0.03%	606
2020 Q3	–	Sell	-12,689	Closed	-$224K	–	1067
2020 Q2	$224K	Buy	+12,689	New	+$224K	0.03%	678